These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10704770)

  • 1. Transthyretin binds amyloid beta peptides, Abeta1-42 and Abeta1-40 to form complex in the autopsied human kidney - possible role of transthyretin for abeta sequestration.
    Tsuzuki K; Fukatsu R; Yamaguchi H; Tateno M; Imai K; Fujii N; Yamauchi T
    Neurosci Lett; 2000 Mar; 281(2-3):171-4. PubMed ID: 10704770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
    Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
    J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transthyretin neuroprotection in Alzheimer's disease is dependent on proteolysis.
    Silva CS; Eira J; Ribeiro CA; Oliveira Â; Sousa MM; Cardoso I; Liz MA
    Neurobiol Aging; 2017 Nov; 59():10-14. PubMed ID: 28780366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The catalytic kinetics of chicken transthyretin towards human Aβ
    Tola AJ; Leelawatwattana L; Prapunpoj P
    Comp Biochem Physiol C Toxicol Pharmacol; 2019 Dec; 226():108610. PubMed ID: 31454704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Cyclic Peptide Mimic of the β-Amyloid Binding Domain on Transthyretin.
    Cho PY; Joshi G; Boersma MD; Johnson JA; Murphy RM
    ACS Chem Neurosci; 2015 May; 6(5):778-89. PubMed ID: 25713928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease.
    Alemi M; Silva SC; Santana I; Cardoso I
    CNS Neurosci Ther; 2017 Jul; 23(7):605-619. PubMed ID: 28570028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transthyretin variants with improved inhibition of β-amyloid aggregation.
    Mangrolia P; Yang DT; Murphy RM
    Protein Eng Des Sel; 2016 Jun; 29(6):209-218. PubMed ID: 27099354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro.
    Li X; Zhang X; Ladiwala AR; Du D; Yadav JK; Tessier PM; Wright PE; Kelly JW; Buxbaum JN
    J Neurosci; 2013 Dec; 33(50):19423-33. PubMed ID: 24336709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calorimetric Studies of Binary and Ternary Molecular Interactions between Transthyretin, Aβ Peptides, and Small-Molecule Chaperones toward an Alternative Strategy for Alzheimer's Disease Drug Discovery.
    Cotrina EY; Gimeno A; Llop J; Jiménez-Barbero J; Quintana J; Valencia G; Cardoso I; Prohens R; Arsequell G
    J Med Chem; 2020 Mar; 63(6):3205-3214. PubMed ID: 32124607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transthyretin Suppresses Amyloid-β Secretion by Interfering with Processing of the Amyloid-β Protein Precursor.
    Li X; Song Y; Sanders CR; Buxbaum JN
    J Alzheimers Dis; 2016 Apr; 52(4):1263-75. PubMed ID: 27079720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Positive Side of the Alzheimer's Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1.
    Ciccone L; Shi C; di Lorenzo D; Van Baelen AC; Tonali N
    Molecules; 2020 May; 25(10):. PubMed ID: 32456156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of cellular toxicity of amyloid-β by dissociated transthyretin.
    Cao Q; Anderson DH; Liang WY; Chou J; Saelices L
    J Biol Chem; 2020 Oct; 295(41):14015-14024. PubMed ID: 32769117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of amyloid beta fibril formation by monomeric human transthyretin.
    Garai K; Posey AE; Li X; Buxbaum JN; Pappu RV
    Protein Sci; 2018 Jul; 27(7):1252-1261. PubMed ID: 29498118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of transthyretin with amyloid beta-protein: binding and inhibition of amyloid formation.
    Schwarzman AL; Goldgaber D
    Ciba Found Symp; 1996; 199():146-60; discussion 160-4. PubMed ID: 8915609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protease activity of transthyretin reverses the effect of pH on the amyloid-β protein/heparan sulfate proteoglycan interaction: a biochromatographic study.
    Geneste A; Guillaume YC; Magy-Bertrand N; Lethier L; Gharbi T; André C
    J Pharm Biomed Anal; 2014 Aug; 97():88-96. PubMed ID: 24858299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper mediated amyloid-β binding to Transthyretin.
    Ciccone L; Fruchart-Gaillard C; Mourier G; Savko M; Nencetti S; Orlandini E; Servent D; Stura EA; Shepard W
    Sci Rep; 2018 Sep; 8(1):13744. PubMed ID: 30213975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinol-Binding Protein Interferes with Transthyretin-Mediated β-Amyloid Aggregation Inhibition.
    Mangrolia P; Murphy RM
    Biochemistry; 2018 Aug; 57(33):5029-5040. PubMed ID: 30024734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transthyretin Interferes with Aβ Amyloid Formation by Redirecting Oligomeric Nuclei into Non-Amyloid Aggregates.
    Nilsson L; Pamrén A; Islam T; Brännström K; Golchin SA; Pettersson N; Iakovleva I; Sandblad L; Gharibyan AL; Olofsson A
    J Mol Biol; 2018 Aug; 430(17):2722-2733. PubMed ID: 29890120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.